secwatch.observer — SEC 8-K summary
======================================

Issuer:     NewAmsterdam Pharma Co N.V. (NAMS)
CIK:        0001936258
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001193125-26-084266
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NewAmsterdam Pharma files updated corporate presentation, no specific details disclosed
--------------------------------------------------------------------------------

- Company posted an updated investor presentation on its website on March 2, 2026.
- Presentation furnished as Exhibit 99.1 to this Form 8-K but not reproduced in available text.
- No financial or operational updates explicitly provided in the filing text.
- Content of the presentation is unknown; cannot extract specific numbers or events.
- Confidence low due to lack of exhibit content and absence of material disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/0001193125-26-084266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1936258/000119312526084266/nams-20260302.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-084266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer